Nevro Corp.

AI Score

0

Unlock

3.73
0.03 (0.81%)
At close: Jan 15, 2025, 11:56 AM

Nevro Corp. Revenue Breakdown

Quarter Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021
Painful Diabetic Neuropathy Revenue 22.50M 20.80M 19.00M 15.60M 17.60M 13.40M 11.00M 6.00M 1.70M
Painful Diabetic Neuropathy Revenue Growth +8.17% +9.47% +21.79% -11.36% +31.34% +21.82% +83.33% +252.94% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Non-Us Revenue 58.62M 58.20M 326.22M 311.87M 326.01M 321.78M
Non-Us Revenue Growth +0.72% -82.16% +4.60% -4.34% +1.31% n/a
United States Revenue 366.56M 348.17M n/a n/a n/a n/a
United States Revenue Growth +5.28% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 68.47M 76.77M 85.09M 77.82M 81.15M 86.76M 86.19M 80.65M 78.19M 83.97M 79.33M 82.64M 79.52M 73.88M 73.27M 67.07M 68.51M 60.17M 71.40M 76.01M 72.91M 75.57M 81.33M 71.28M 64.01M 64.71M 66.62M 61.74M 52.98M 54.27M 50.72M 43.83M 35.64M 34.31M 28.64M 27.62M 21.90M 19.82M 13.13M
Selling, General, and Administrative Revenue Growth -10.81% -9.78% +9.35% -4.11% -6.47% +0.66% +6.87% +3.15% -6.89% +5.86% -4.01% +3.92% +7.64% +0.83% +9.24% -2.10% +13.87% -15.73% -6.06% +4.25% -3.53% -7.08% +14.10% +11.36% -1.08% -2.87% +7.90% +16.54% -2.39% +7.01% +15.71% +23.00% +3.86% +19.79% +3.69% +26.16% +10.46% +50.97% n/a
Research and Development Revenue 10.58M 14.12M 14.83M 12.42M 13.92M 13.32M 14.76M 13.95M 14.03M 12.55M 12.54M 12.71M 11.55M 11.87M 11.53M 11.83M 11.11M 10.44M 12.21M 16.93M 13.02M 14.93M 14.13M 13.48M 12.48M 11.42M 11.09M 9.94M 9.38M 9.54M 8.70M 11.28M 7.92M 8.17M 6.36M 5.87M 5.25M 5.26M 5.00M
Research and Development Revenue Growth -25.06% -4.79% +19.39% -10.80% +4.53% -9.73% +5.79% -0.59% +11.78% +0.13% -1.36% +10.01% -2.66% +2.90% -2.50% +6.44% +6.42% -14.48% -27.88% +30.06% -12.80% +5.62% +4.86% +8.03% +9.30% +2.99% +11.49% +5.99% -1.64% +9.63% -22.85% +42.32% -3.01% +28.42% +8.29% +11.95% -0.30% +5.30% n/a